396 results
Page 4 of 20
8-K
EX-1.1
jcbw3lf7y6b
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
424B5
x8rq7t2h6bttejmeg
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
a9vpve
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
k7rdh
26 Jan 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-1.1
uswwq6
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
424B5
qdvn9dso9vu2jtxsp
25 Jan 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
c1oohin758mgvti
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
424B3
xhd5x
4 Dec 20
Prospectus supplement
4:48pm
8-K
yh3p9mhzgdn3z
13 Nov 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm